Sex Differences in 1-Year Rehospitalization for Heart Failure and Myocardial Infarction After Primary Percutaneous

Huili Zheng1, Ling Li Foo1, Huay Cheem Tan2

  • 1National Registry of Diseases Office, Health Promotion Board, Singapore.

Insights

Universal primary percutaneous coronary intervention (pPCI) access equalized heart failure (HF) rehospitalization between sexes after ST-elevation myocardial infarction (STEMI). However, women, particularly older women, still faced higher rehospitalization risks for myocardial infarction (MI).

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Health Services Research

Background:

  • Sex differences in outcomes after ST-elevation myocardial infarction (STEMI) persist despite advancements in treatment.
  • The impact of universal primary percutaneous coronary intervention (pPCI) access on reducing these sex disparities requires further investigation.
  • Understanding rehospitalization patterns for heart failure (HF) and myocardial infarction (MI) is crucial for improving post-STEMI care.

Purpose of the Study:

  • To evaluate whether universal access to pPCI mitigates sex differences in 1-year rehospitalization for HF and MI post-STEMI.
  • To identify specific patient groups or conditions contributing to persistent sex disparities in rehospitalization.

Main Methods:

  • A cohort of 7,597 STEMI patients undergoing pPCI between January 2007 and December 2013 was analyzed.
  • Cox regression models, adjusted for competing risks of death, assessed sex differences in 1-year rehospitalization for HF and MI.
  • Baseline characteristics, comorbidities, treatment variations, and discharge medications were compared between sexes.

Main Results:

  • Women were older, had more comorbidities, and experienced longer door-to-balloon times compared to men.
  • After adjustment, sex differences in HF rehospitalization risk were attenuated (HR 1.05), but persisted for MI (HR 1.68).
  • The disparity in MI rehospitalization was more pronounced in women aged 60 years and older.

Conclusions:

  • Universal pPCI access led to similar 1-year HF rehospitalization rates for men and women post-STEMI.
  • A significant, adjusted higher risk of 1-year MI rehospitalization persists in women, especially older women.
  • Targeted strategies are needed to address sex-specific disparities in MI recurrence and management post-STEMI.

Related Concept Videos

Heart Failure VII: Nursing Interventions01:30

Heart Failure VII: Nursing Interventions

The first step in nursing management of a patient with heart failure involves thoroughly assessing the patient's medical history.Subjective Data: Obtain the patient's medical history of coronary artery disease, hypertension, myocardial infarction, and symptoms like dyspnea, orthopnea, and paroxysmal nocturnal dyspnea.Objective Data: Conduct a physical examination to identify findings such as jugular vein distention, pulmonary crackles, tachycardia, murmurs, peripheral edema, and vital signs,...
464
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
837
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
3.2K
Heart Failure I: Introduction01:27

Heart Failure I: Introduction

Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
776
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
301
Primary Motives: Sleep, Sex, and Pain Avoidance01:24

Primary Motives: Sleep, Sex, and Pain Avoidance

Primary motives such as sleep, sex, and pain avoidance are crucial drivers of behavior in humans and animals. These motives ensure survival, reproductive success, and overall well-being by prompting actions that meet essential bodily needs.
Sleep is a fundamental physiological drive that fosters a state of restfulness crucial for several bodily functions. It facilitates body restoration, the process by which the body repairs, rejuvenates, and maintains itself during sleep, including memory...
5.5K